CN Patent

CN103570657A — 一类含偕二甲基的苯基c-葡萄糖苷衍生物、其制备方法和用途

Assigned to Tianjin Institute of Pharmaceutical Research Co Ltd · Expires 2014-02-12 · 12y expired

What this patent protects

本发明涉及与糖尿病相关的药物领域。具体而言，本发明涉及一类含偕二甲基的苯基C-葡萄糖苷结构的2型钠半乳糖转运子(SGLT2)抑制剂、其制备方法、及含有它们的药物组合物以及它们在制备糖尿病药物中的应用。

USPTO Abstract

本发明涉及与糖尿病相关的药物领域。具体而言，本发明涉及一类含偕二甲基的苯基C-葡萄糖苷结构的2型钠半乳糖转运子(SGLT2)抑制剂、其制备方法、及含有它们的药物组合物以及它们在制备糖尿病药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN103570657A
Jurisdiction
CN
Classification
—
Expires
2014-02-12
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Institute of Pharmaceutical Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.